Clinical Trial Results:
A Randomised Double-Blind Placebo-Controlled Phase III Clinical
Study to Evaluate the Efficacy and Safety of Cobitolimod as an
Induction and Maintenance Therapy in Participants with Moderate
to Severe Active Left-Sided Ulcerative Colitis
Summary
|
|
EudraCT number |
2021-002549-13 |
Trial protocol |
SE DE HU FR SK LT IT AT PT NO BE DK HR NL BG |
Global completion date |
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
01 Jun 2024
|
First version publication date |
01 Jun 2024
|
Other versions |
|
Summary report(s) |
CONCLUDE CSUC-01-21_CSR_incl cover letter_Final_15May2024 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.